{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:15:54Z","timestamp":1791278154522,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T00:00:00Z","timestamp":1237507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/hr.2009.29","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T09:40:49Z","timestamp":1237542049000},"page":"321-324","source":"Crossref","is-referenced-by-count":33,"title":["Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension"],"prefix":"10.1038","volume":"32","author":[{"given":"Yoshiyu","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,20]]},"reference":[{"key":"BFhr200929_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/HYPERTENSIONAHA.107.098897","volume":"51","author":"N Makhanova","year":"2008","unstructured":"Makhanova N, Hagaman J, Kim H-S, Smithies O . Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008; 51: 134\u2013140.","journal-title":"Hypertension"},{"key":"BFhr200929_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/ajplegacy.1957.189.3.451","volume":"189","author":"L Tobian","year":"1957","unstructured":"Tobian L, Redleaf PD . Effect of hypertension on arterial wall electrolytes during deoxycorticosterone administration. Am J Physiol 1957; 189: 451\u2013454.","journal-title":"Am J Physiol"},{"key":"BFhr200929_CR3","first-page":"188","volume":"6","author":"L Kornel","year":"1988","unstructured":"Kornel L, Rafelson ME, Hayashi T, Kanamarlapudi N, Anderson KM . Receptors for adrenal steroids and transport of electrolytes in vascular smooth muscle. Clin Physiol Biochem 1988; 6: 188\u2013200.","journal-title":"Clin Physiol Biochem"},{"key":"BFhr200929_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"C Farquharson","year":"2000","unstructured":"Farquharson C, Struthers AD . Spironolactone increases NO bioactivity, improves endothelial dysfunction and suppresses vascular AI\/AII conversion in chronic heart failure. Circulation 2000; 101: 594\u2013597.","journal-title":"Circulation"},{"key":"BFhr200929_CR5","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","volume":"109","author":"M Nishizaka","year":"2004","unstructured":"Nishizaka M, Zaman MA, Sharon A, Green SA, Renfroe KY, Calhoun DA . Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 2004; 109: 2857\u20132861.","journal-title":"Circulation"},{"key":"BFhr200929_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT . Remodeling of the right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355\u20131364.","journal-title":"Circ Res"},{"key":"BFhr200929_CR7","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1210\/en.2002-220120","volume":"143","author":"R Rocha","year":"2002","unstructured":"Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E . Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart. Endocrinology 2002; 143: 4828\u20134836.","journal-title":"Endocrinology"},{"key":"BFhr200929_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1291\/hypres.30.979","volume":"30","author":"S Kagiyama","year":"2007","unstructured":"Kagiyama S, Matsumura K, Fukuhara M, Sakagami K, Fujii K, Iida M . Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice. Hypertens Res 2007; 30: 979\u2013989.","journal-title":"Hypertens Res"},{"key":"BFhr200929_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1291\/hypres.31.1251","volume":"31","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Saito Y, Naya N, Imagawa K, Somekawa S, Kawata H, Takeda Y, Uemura S, Kishimoto I, Nakao K . The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A. Hypertens Res 2008; 31: 1251\u20131256.","journal-title":"Hypertens Res"},{"key":"BFhr200929_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1291\/hypres.29.627","volume":"29","author":"A Urabe","year":"2006","unstructured":"Urabe A, Izumi T, Abe Y, Taniguchi I, Mochizuki S . Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats. Hypertens Res 2006; 29: 627\u2013634.","journal-title":"Hypertens Res"},{"key":"BFhr200929_CR11","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1073\/pnas.2336140100","volume":"100","author":"M Ehrhart-Bornstein","year":"2003","unstructured":"Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR . Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211\u201314216.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200929_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","volume":"50","author":"M Nagase","year":"2007","unstructured":"Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T . Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor, role of oxidative stress. Hypertension 2007; 50: 877\u2013883.","journal-title":"Hypertension"},{"key":"BFhr200929_CR13","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1096\/fj.06-7970com","volume":"21","author":"M Caprio","year":"2007","unstructured":"Caprio M, F\u00e8ve B, Cla\u00ebs A, Viengchareun S, Lomb\u00e8s M, Zennaro M-C . Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007; 21: 2185\u20132194.","journal-title":"FASEB J"},{"key":"BFhr200929_CR14","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2007-1088","volume":"92","author":"R Bentley-Lewis","year":"2007","unstructured":"Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH, Garg R . Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92: 4472\u20134475.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr200929_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1291\/hypres.30.1077","volume":"30","author":"Y Ohta","year":"2007","unstructured":"Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M . Prevalence and lifestyle characteristics of hypertensive patients with metabolic syndrome followed at an outpatient clinic in Fukuoka, Japan. Hypertens Res 2007; 30: 1077\u20131082.","journal-title":"Hypertens Res"},{"issue":"Part 2","key":"BFhr200929_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","volume":"49","author":"S Kidambi","year":"2007","unstructured":"Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, Kotchen TA . Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007; 49 (Part 2): 704\u2013711.","journal-title":"Hypertension"},{"key":"BFhr200929_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1172\/JCI17845","volume":"112","author":"H Masuzaki","year":"2003","unstructured":"Masuzaki H, Yamamoto H, Christopher J, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MGF, Fleming S, Mullins JJ, Seckl JR, Jeffrey S, Flieret JS . Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83\u201390.","journal-title":"J Clin Invest"},{"key":"BFhr200929_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/01.HYP.32.6.1077","volume":"32","author":"Y Takeda","year":"1998","unstructured":"Takeda Y, Inaba S, Furukawa K, Miyamori I . Renal 11\u03b2-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats. Hypertension 1998; 32: 1077\u20131082.","journal-title":"Hypertension"},{"key":"BFhr200929_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","volume":"20","author":"Y Takeda","year":"2007","unstructured":"Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M . Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Am J Hytertens 2007; 20: 1119\u20131124.","journal-title":"Am J Hytertens"},{"key":"BFhr200929_CR20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","volume":"47","author":"M Nagase","year":"2006","unstructured":"Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T . Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47: 1084\u20131093.","journal-title":"Hypertension"},{"key":"BFhr200929_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","volume":"43","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin E . Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2004; 43: 1252\u20131257.","journal-title":"Hypertension"},{"key":"BFhr200929_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000056768.03657.B4","volume":"41","author":"H Kobori","year":"2003","unstructured":"Kobori H, Nishiyama A, Abe Y, Navar LG . Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003; 41: 592\u2013597.","journal-title":"Hypertension"},{"key":"BFhr200929_CR23","doi-asserted-by":"crossref","unstructured":"Zhu A, Yoneda T, Demura M, Karashima S, Usukura M, Yagi K, Yamagishi M, Takeda Y . Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin-system in Dahl salt-sensitive hypertensive rats. J Hypertens 2009 (In press).","DOI":"10.1097\/HJH.0b013e328325d861"},{"key":"BFhr200929_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","volume":"96","author":"IZ Jaffe","year":"2005","unstructured":"Jaffe IZ, Mendelsohn ME . Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cells. Circ Res 2005; 96: 643\u2013650.","journal-title":"Circ Res"},{"key":"BFhr200929_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00109-008-0343-1","volume":"86","author":"T Fujita","year":"2008","unstructured":"Fujita T . Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med 2008; 86: 729\u2013734.","journal-title":"J Mol Med"},{"key":"BFhr200929_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T . Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nature Med 2008; 14: 1370\u20131376.","journal-title":"Nature Med"},{"key":"BFhr200929_CR27","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","volume":"41","author":"JM Flack","year":"2003","unstructured":"Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH, Yang Y, Krause SL, Workman D, Saunders E . Efficacy and tolerability of eplerenone and losartan in black and white patients. Am J Coll Cardiol 2003; 41: 1148\u20131155.","journal-title":"Am J Coll Cardiol"},{"key":"BFhr200929_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","volume":"48","author":"AJ Zillich","year":"2006","unstructured":"Zillich AJ, Garg J, Basu S, Bakins GL, Carter BL . Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 219\u2013224.","journal-title":"Hypertension"},{"key":"BFhr200929_CR29","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1093\/ndt\/gfm409","volume":"11","author":"T Fujita","year":"2007","unstructured":"Fujita T . Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol Dial Transplant 2007; 11: 3102\u20133107.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr200929_CR30","doi-asserted-by":"publisher","first-page":"F377","DOI":"10.1152\/ajprenal.00143.2002","volume":"283","author":"E Kamynina","year":"2002","unstructured":"Kamynina E, Staub O . Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport. Am J Physiol Renal Physiol 2002; 283: F377\u2013F387.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFhr200929_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1291\/hypres.24.469","volume":"24","author":"Y Takeda","year":"2001","unstructured":"Takeda Y . Genetic alterations in patients with primary aldosteronism. Hypertens Res 2001; 24: 469\u2013474.","journal-title":"Hypertens Res"},{"key":"BFhr200929_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"Karagiannis A, Triomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP . Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 2008; 9: 509\u2013515.","journal-title":"Expert Opin Pharmacother"},{"key":"BFhr200929_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.jhh.1002070","volume":"20","author":"P Gosse","year":"2006","unstructured":"Gosse P, Macfadyen RJ . Does eplerenone have a future in the management of hypertension in Europe? J Human Hypertens 2006; 20: 829\u2013832.","journal-title":"J Human Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr200929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr200929","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr200929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:04:33Z","timestamp":1684429473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr200929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,20]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFhr200929"],"URL":"https:\/\/doi.org\/10.1038\/hr.2009.29","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,20]]}}}